We have shown previously that AXL is ubiquitously expressed and constitutively active in CLL cells [17, 19], remains significantly elevated in cells with non-functional p53 [19] and regulates cell survival via activation of multiple downstream signal mediators. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.